6.5 C
New York
Sunday, November 28, 2021

Aspirin reduces the risk of dying from cancer by a fifth but one side effect – Says Study

Must Read

A massive asteroid stronger than an atom bomb is approaching Earth: how dangerous can it be?

The asteroid 2018 AH is expected to be roughly 190 meters long, similar to the Tunguska asteroid,...

Giving Tuesday: a chance to make a real difference for others and ourselves after Black Friday and Cyber Monday

Giving Tuesday 2021: After Black Friday and Cyber Monday, a chance to truly help others and ourselves.

JPMorgan’s chief might regret his comments about China’s CCP but he has a point

Comparing JPMorgan to the Chinese Communist Party is bold and hubristic. Despite his later regrets for boasting...
Jiya Saini
Jiya Saini is a Journalist and Writer at Revyuh.com. She has been working with us since January 2018. After studying at Jamia Millia University, she is fascinated by smart lifestyle and smart living. She covers technology, games, sports and smart living, as well as good experience in press relations. She is also a freelance trainer for macOS and iOS, and In the past, she has worked with various online news magazines in India and Singapore. Email: jiya (at) revyuh (dot) com

According to a new study, aspirin could help reduce the growth of cancer within the body.

After reviewing 118 research studies, Professor Peter Elwood and his team from Cardiff University said there is “a considerable body of evidence” to suggest that painkillers ‘greatly reduce the risk of death’ in cancer patients.

“Aspirin, therefore, appears to deserve serious consideration as an adjuvant treatment of cancer,” said Elwood.

“Patients with cancer and their carers should be informed of the available evidence.”

Elwood’s research included 18 patients with different kinds of cancer, with the results showing that aspirin could be helpful in controlling all of them.

“There is now a considerable body of evidence to suggest a significant reduction in mortality in patients with cancer who take aspirin,” said Elwood.

“And that benefit appears to not be restricted to one or a few cancers,” Elwood stressed.

The results of study showed that in 250,000 cancer patients who reported having aspirin, their risk of dying from cancer was redueced to about 20 per cent than those who didn’t take aspirin.

As being an observational study, it can’t prove causes and effects, meaning the research doesn’t prove that aspirin directly prevents cancer from spreading.

However, the study does justify aspirin’s use “as an adjunct treatment in a wide range of cancers”.

“We must also stress that aspirin is not a possible alternative to any other treatment,” Elwood warned.

One main side effect of taking aspirin is the risk of bleeding in the gastrointestinal system.

Thus the scientists of the research requested additional information on the side effects experienced by cancer patients taking aspirin.

As it was expected, the frequency of bleeding did increase with cancer patients who were taking aspirin.

However, “fatal bleeding was rare and no author reported a significant excess in fatal bleeds associated with aspirin”.

With more than 200 known cancers, Elwood believes research into some of the lesser-known cancers would also be beneficial.

Image Credit: Getty

- Advertisement -
- Advertisement -

Latest News

- Advertisement -

More Articles Like This

- Advertisement -